Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In this episode, Don and Steve dig into the evidence behind the most talked-about risks of GLP-1 agonists , separating clinical truth from rumors and headlines
not a drug, food, or cosmetic Legal note Buyer assumes all responsibility for safe handling and compliance with local regulations
This ensures correct dosing, proper screening for contraindications, and monitoring of side effects
Quality, long-term data on 5-amino-1MQ is lacking
Recent analysis by the American Academy of Actuaries suggested that the high cost of these medications, combined with the need for long-term use, could place upward pressure on 2025 health insurance premiums, particularly as more patients met clinical criteria for covered diagnoses
Compare that to the STEP 1 extension data, where participants regained 11.6 percentage points within 52 weeks of stopping semaglutide without any structured dietary intervention
